Basic Information
| ID | DRAMP21262 |
|---|
| Sequence | AAKLLLKLLLKAA |
|---|
| Length | 13 |
|---|
| Name | KL6A4 (De novo synthesis) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram- |
|---|
| Pathogen | [Ref.26385363] Gram-positive bacteria : Staphylococcus aureus ATCC 29213(MIC=32 μM), Staphylococcus epidermidis ATCC 12228(MIC=16 μM), Streptococcus faecalis ATCC 29212(MIC=16 μM), Bacillus subtilis CMCC 63501(MIC=16 μM);##Gram-negative bacteria : Escherichia coli ATCC25922(MIC=1 μM), Escherichia coli K88(MIC=16 μM), Escherichia coli CVCC 1515(MIC=16 μM), Escherichia coli UB1005(MIC=32 μM), Bacterium pyocyaneum ATCC 27853(MIC>128 μM), Salmonella typhimurium ATCC 14028(MIC>128 μM), Salmonella pullorum C79–13(MIC>128 μM) |
|---|
| Hemolytic Activity | [Ref.26385363] MHC5=8 μM against human red blood cells |
|---|
| Cytotoxicity | [Ref.26385363] The cell viability of HEK293 cells induced by KL6A4 is 102.8%, 109.4%, 103.9%, 109.4%, 105.3%, 90.6%, 83.1% and 81.7% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM. The cell viability of HEK293 cells induced by control Me |
|---|
| N-terminal Modification | Free |
|---|
| C-terminal Modification | Amidation |
|---|
| Linear/Cyclic/Branched | Linear |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 26385363 |
|---|
